Follow
Craig Schindewolf
Craig Schindewolf
Verified email at seattlechildrens.org
Title
Cited by
Cited by
Year
Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States
J Harcourt, A Tamin, X Lu, S Kamili, SK Sakthivel, J Murray, K Queen, ...
Emerging infectious diseases 26 (6), 1266, 2020
6332020
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ...
Nature 591 (7849), 293-299, 2021
6112021
An infectious cDNA clone of SARS-CoV-2
X Xie, A Muruato, KG Lokugamage, K Narayanan, X Zhang, J Zou, J Liu, ...
Cell host & microbe 27 (5), 841-848. e3, 2020
6092020
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Y Liu, J Liu, BA Johnson, H Xia, Z Ku, C Schindewolf, SG Widen, Z An, ...
Cell reports 39 (7), 2022
3622022
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
Y Liu, J Liu, KS Plante, JA Plante, X Xie, X Zhang, Z Ku, Z An, D Scharton, ...
Nature 602 (7896), 294-299, 2022
3532022
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV
KG Lokugamage, A Hage, M de Vries, AM Valero-Jimenez, ...
Journal of virology 94 (23), 10.1128/jvi. 01410-20, 2020
3432020
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
BA Johnson, Y Zhou, KG Lokugamage, MN Vu, N Bopp, ...
PLoS pathogens 18 (6), e1010627, 2022
972022
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
A Tamir, U Jag, S Sarojini, C Schindewolf, T Tanaka, R Gharbaran, ...
Journal of ovarian research 7, 1-15, 2014
882014
Middle East respiratory syndrome vaccine candidates: cautious optimism
C Schindewolf, VD Menachery
Viruses 11 (1), 74, 2019
852019
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
A Muruato, MN Vu, BA Johnson, ME Davis-Gardner, A Vanderheiden, ...
PLoS biology 19 (11), e3001284, 2021
592021
Development of highly potent noncovalent inhibitors of SARS-CoV-2 3CLpro
N Hou, L Shuai, L Zhang, X Xie, K Tang, Y Zhu, Y Yu, W Zhang, Q Tan, ...
ACS central science 9 (2), 217-227, 2023
352023
QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis
MN Vu, KG Lokugamage, JA Plante, D Scharton, AO Bailey, S Sotcheff, ...
Proceedings of the National Academy of Sciences 119 (32), e2205690119, 2022
292022
SARS-CoV-2 uses nonstructural protein 16 to evade restriction by IFIT1 and IFIT3
C Schindewolf, K Lokugamage, MN Vu, BA Johnson, D Scharton, ...
Journal of virology 97 (2), e01532-22, 2023
182023
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development
MA Files, CA Hansen, VC Herrera, C Schindewolf, ADT Barrett, ...
npj Vaccines 7 (1), 38, 2022
152022
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection
MN Vu, RE Alvarado, DR Morris, KG Lokugamage, Y Zhou, AL Morgan, ...
BioRxiv, 2023
82023
Complex patterns in networks of hyperexcitable neurons
C Schindewolf, D Kim, A Bel, HG Rotstein
Theoretical Computer Science 633, 71-82, 2016
62016
Coronavirus 2′-O-methyltransferase: A promising therapeutic target
C Schindewolf, VD Menachery
Virus Research 336, 199211, 2023
12023
The N501Y spike substitution enhances SARS-CoV-2 transmission (preprint)
S Weaver, Y Liu, J Liu, K Plante, J Plante, X Xie, X Zhang, Z Ku, Z An, ...
12021
Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge (preprint)
A Muruato, M Vu, BA Johnson, M Davis-Gardner, AR Vanderheiden, ...
12021
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection (preprint)
MN Vu, DR Morris, RE Alvarado, KG Lokugamage, Y Zhou, LK Estes, ...
2023
The system can't perform the operation now. Try again later.
Articles 1–20